Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.

Lalonde L, Quintana-Bárcena P, Lord A, Bell R, Clément V, Daigneault AM, Legris MÈ, Letendre S, Mouchbahani M, Jouini G, Azar J, Martin É, Berbiche D, Beaulieu S, Beaunoyer S, Bertin É, Bouvrette M, Charbonneau-Séguin N, Desrochers JF, Desforges K, Dumoulin-Charette A, Dupuis S, El Bouchikhi M, Forget R, Guay M, Lemieux JP, Morin-Bélanger C, Noël I, Ricard S, Sauvé P, Ste-Marie Paradis F.

Am J Kidney Dis. 2017 Sep;70(3):386-396. doi: 10.1053/j.ajkd.2017.05.008. Epub 2017 Jun 26.

PMID:
28663062
2.

Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.

Rauscher S, Lafrance JP, Pichette V, Bell RZ, Desforges K, Lepage L, Ouellet G, Ouimet D, Leblanc M, Lamarche C, Bezzaoucha S, Vallee M.

Int Urol Nephrol. 2017 Feb;49(2):325-328. doi: 10.1007/s11255-016-1446-1. Epub 2016 Nov 8.

PMID:
27822674
3.

New drugs to prevent and treat hyperkalemia.

Lepage L, Desforges K, Lafrance JP.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):524-528. Review.

PMID:
27584929
4.

Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.

Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17.

5.

Pharmacist Web-based training program on medication use in chronic kidney disease patients: impact on knowledge, skills, and satisfaction.

Legris MÈ, Séguin NC, Desforges K, Sauvé P, Lord A, Bell R, Berbiche D, Desrochers JF, Lemieux JP, Morin-Bélanger C, Ste-Marie Paradis F, Lalonde L.

J Contin Educ Health Prof. 2011 Summer;31(3):140-50. doi: 10.1002/chp.20119.

PMID:
21953653
6.

Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.

Desrochers JF, Lemieux JP, Morin-Bélanger C, Paradis FS, Lord A, Bell R, Berbiche D, Bárcena PQ, Séguin NC, Desforges K, Legris MÈ, Sauvé P, Lalonde L.

Am J Kidney Dis. 2011 Oct;58(4):527-35. doi: 10.1053/j.ajkd.2011.04.020. Epub 2011 Jul 20.

PMID:
21778005

Supplemental Content

Loading ...
Support Center